Please assess the completion status of the following clinical trial:

Trial Title: Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients have to fulfill all of the following inclusion criteria to be eligible for participation in this study:~1. Men, women\*, inter/divers, age ≥18 and ≤ 80 years (conscious or unconscious patients may be included)~2. Signed written informed consent obtained by patient or legal representative in case of unconscious patient~3. Willingness to comply with treatment and follow-up procedures~4. Suspected SSC-CIP = episode of critical illness and intensive care unit treatment \> 3 days within last 12 months~5. SSC-CIP is confirmed by ERC, (if the first ERC is performed at baseline, the patient may be considered as screening failure if the diagnosis is not confirmed)~6. Elevation of bilirubin ≥ 2.5 upper limit of normal (ULN) at Screening~7. Elevation of alkaline phosphatase (AP) or gamma-glutamyl-transferase (GGT) \> 2.5 ULN or elevation of both at Screening~8. \*Women without childbearing potential defined as follows:~   * at least 6 weeks after surgical sterilization by bilateral tubal ligation or bilateral oophorectomy or~  * hysterectomy or uterine agenesis or~  * ≥ 50 years and in postmenopausal state \> 1 year or~  * \< 50 years and in postmenopausal state \> 1 year with serum Follicle Stimulating Hormone (FSH) \> 40 IU/l and serum estrogen \< 30 ng/l or a negative estrogen test, both at screening or~     \*Women of childbearing potential:~  * who are practicing sexual abstinence (periodic abstinence and withdrawal are not acceptable) or~  * who have sexual relationships with female partners only and/or with sterile male partners or~  * who are sexually active with fertile male partner, have a negative pregnancy test during screening and agree to use reliable methods of contraception (failure rate of \< 1% per year) from the time of screening until end of the clinical trial.~Exclusion Criteria:~1. Patient is too unstable to undergo ERC~2. Inclusion in any other intervention trial within the last 30 days~3. Pregnancy or lactation period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- interventional (Type: EXPERIMENTAL): The intervention group undergoes scheduled invasive evaluation of the biliary tract with endoscopic retrograde cholangiography (ERC) with biliary interventions (i.e. therapeutic ERC) every 8 weeks for 6 months.
- control (Type: NO_INTERVENTION): The control group receives non-interventional standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).